0001958777
EX-FILING FEES
0.0001381
0001958777
2025-12-23
2025-12-23
0001958777
1
2025-12-23
2025-12-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
FORM
S-1
(Form
Type)
FibroBiologics,
Inc.
(Exact
Name of Registrant as Specified in its Charter)
Fees
Previously Paid
Table
1: Newly Registered Securities
Security Type | |
Security Class Title | |
Fee Calculation Rule | |
Amount Registered | (1) | |
Proposed Maximum Offering Price Per Unit | | |
Maximum Aggregate Offering Price | | |
Fee Rate | |
Amount of Registration Fee | |
| Fees to be Paid | |
| |
| |
| | | |
| | | |
| | | |
| |
| | |
| Equity | |
Common stock, par value $0.00001 per share, underlying warrants | |
Rule 457(c) | |
| 22,494,434 | | |
$ | 0.2565 | (2) | |
$ | 5,769,823 | | $ |
138.10 per 1,000,000 | |
$ | 797 | |
| | |
| |
| |
| | | |
| | | |
| | | |
| |
| | |
| Total Offering Amounts | | |
$ | 5,769,823 | | |
| |
$ | 797 | |
| Total Fee Offsets | | |
| | | |
| |
| — | |
| Net Fee Due | | |
| | | |
| |
$ | 797 | |
| |
(1) |
Pursuant
to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement on Form S-1 shall be
deemed to cover any additional shares of common stock, par value $0.00001 per share, or the Common Stock, of FibroBiologics, Inc.
that may be issued as a result of any stock dividend, stock split, recapitalization or other similar transaction, and any other securities
with respect to which the outstanding shares are converted or exchanged. |
| |
|
|
| |
(2) |
Estimated
solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average
of the high and low sales price of Common Stock as reported on the Nasdaq Capital Market on December 19, 2025. |
N/A